Inclusion Criteria:~1. Confirmed diagnosis of Alzheimer's Disease (AD) with documented positive amyloid beta
signal via positron emission tomography (PET) brain scan~2. Must be willing to consent to genotyping for
apolipoprotein E (APOE)~3. Ability to fixate and undergo retinal imaging of both eyes~
